KRAS P.G12C
Clinical trials for KRAS P.G12C explained in plain language.
Never miss a new study
Get alerted when new KRAS P.G12C trials appear
Sign up with your email to follow new studies for KRAS P.G12C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for elderly lung cancer patients: targeted pill shows promise
Disease control OngoingThis study tests a daily pill called adagrasib in 68 patients with a specific type of advanced lung cancer (KRAS G12C mutation) who are either 70 or older or have poor physical health. The goal is to see if the drug can shrink tumors or stop them from growing. Patients take the m…
Matched conditions: KRAS P.G12C
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Blood samples reveal secrets of drug resistance in KRAS cancers
Knowledge-focused OngoingThis study collects blood samples from up to 500 adults across the US who have KRAS G12C cancer that stopped responding to targeted drugs like sotorasib or adagrasib. Participants provide a simple blood draw at a local lab, and researchers analyze the samples to find genetic chan…
Matched conditions: KRAS P.G12C
Sponsor: Addario Lung Cancer Medical Institute • Aim: Knowledge-focused
Last updated May 26, 2026 11:07 UTC